Taltz — Medical Mutual

Initial criteria

• Patient is age ≥ 6 years
• Patient has tried at least one traditional systemic agent for psoriasis for ≥ 3 months, unless intolerant OR patient has a contraindication to methotrexate
• Prescribed by or in consultation with a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 3 months
• Patient experienced a beneficial clinical response compared with baseline in at least one of: estimated body surface area, erythema, induration/thickness, and/or scale of areas affected by psoriasis
• Compared with baseline, patient experienced an improvement in at least one symptom such as decreased pain, itching, and/or burning

Approval duration

Initial: 3 months; Reauth: 1 year